The mission of Journal of Clinical Pathways® (JCP®) is to provide a platform for original research, insights, and perspectives on clinical pathways and other value-based approaches in health care. The convergence of innovations in big data and incentives for practicing value-based medicine has brought clinical pathways to the forefront as a means to drive precision and optimization of care for patients. The journal provides a forum for discussions of advancements in real-world data and the development of defined treatment pathways in order to address rising costs, mitigate patient risk, reduce variability, and achieve better, more predictable outcomes.
JCP accepts articles on issues related to the development, implementation, and evaluation of clinical pathways. Relevant topics include comparative-effectiveness research; big data analytics; methods in clinical pathway development; optimization of clinical pathway implementation and adherence; health economics and outcomes research; patient-centered outcomes; and alternative payment and value-based care models. Although oncology is a particular area of focus, JCP accepts articles pertaining to all disease treatment settings.
JCP is published in conformance with the Principles of Transparency and Best Practice in Scholarly Publishing. No fees or charges are required for manuscript processing and/or publishing materials in the journal.
Authors interested in submitting to JCP should follow the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. All articles submitted to JCP must be original; the journal does not accept manuscripts whose content has been previously published elsewhere, in print or online. Any instances of research and publication misconduct will be handled in accordance with the Committee on Publication Ethics (COPE) guidelines.
Manuscripts may be submitted online. Authors should fill out the requested information and then upload their manuscript and supporting files in the required formats. Alternatively, authors may email their submissions directly to the Editors via email at: email@example.com.
To facilitate blind peer-review of manuscripts, please do not include author names, affiliations, or contact information in the submitted manuscript document. Please provide this information separately in a cover letter submitted with the manuscript. The manuscript as well as the cover letter should be submitted as Microsoft Word files.
Disclosures of funding sources and financial conflicts of interest must be provided for all authors at the time of manuscript submission. Each author must complete and sign a Financial Disclosure form. As a matter of editorial policy, we will not publish manuscripts that have been written by, or whose development was funded by, a pharmaceutical company, public relations agency, or similar outside source without full disclosure.
Authors must submit a completed Copyright Release Form shortly after submission.
Authors are responsible for obtaining permission and paying fees to reproduce any tables, figures, or other illustrations that were originally published elsewhere; written documentation of this permission should be submitted with the manuscript.
For photographs in which patients are identifiable, authors must include a signed Patient/Parent Consent Form.
All forms can be requested via email at: firstname.lastname@example.org.
On the title page of the manuscript, please provide a title and up to six keywords for your article. An abstract of 100–175 words should be included in the manuscript document. It should be factual, not descriptive, and outline the main points of the paper. Manuscript text should be should be 500–3000 words in length, not including the Abstract and References.
Values should be reported using conventional units of measure. All medications should be referred to by their generic names throughout the manuscript and in all illustrations.
All references should be cited in full and provided in American Medical Association (AMA) style. Please do not use EndNote formatting, as this makes editing difficult. References should be cited in chronological order in the text using superscripted Arabic numerals and included in a citation list at the end of the article.
Tables, figures, and photographs that reflect the general subject matter of the article are encouraged and should accompany the manuscript when first submitted. High-resolution (300 dpi, 4" x 5") JPEG images are preferred. Other acceptable image formats include EPS, PICT, BMP, and TIFF. Please submit images separately from Microsoft Word files. All graphics should be numbered in proper sequence. Legends should be included in the manuscript document.
JCP accepts for consideration the following types of manuscripts: Research Report, Review, From the Field, Case Study, Perspectives, Viewpoint, and Letter to the Editor.
Research Reports are reports of original research pertaining to health economics and outcomes research, clinical pathway development, the evaluation of real-world data, and other investigations related to determination of value in health care.
Review articles provide a thorough, critical, up-to-date overview of the existing literature on a topic relevant to the journal’s mission.
From the Field articles should present timely information on new methods being used to provide value-based care. These articles should have a practical focus and should provide sufficiently detailed information that the reader can implement the approach in their own setting.
Case Studies should present real-world outcomes of using clinical pathways and other value-based treatment approaches in a particular setting. These articles should include detailed information about the approach that was used as well as the methods for evaluating outcomes.
Perspectives articles are less formal in style and should provide unique and evidence-based insights into issues pertaining to the use of clinical pathways and the pursuit of value-based care.
Viewpoints and Letters to the Editor include opinions and commentaries on topics of interest to JCP readers. Letters to the Editor should be written in response to a particular article appearing in a previous issue of the journal or on the JCP website. These submissions are evaluated by at least one expert reviewer prior to acceptance. The Editors reserve the right to decide whether these submissions require full peer review and may invite a response from another contributor to present a counterpoint to the piece.
All manuscripts submitted to JCP for consideration are first reviewed by the Editors for quality and appropriateness for the journal. Selected manuscripts then undergo double-blinded peer review by two or more referees. The corresponding author is notified of the reviewers’ decision within approximately 6–8 weeks of submission. During the review process, the reviewers or Editors often request that the authors revise their manuscript. The final decision on acceptance for publication can be made only after the revised version of the manuscript has been reevaluated.
Accepted manuscripts are edited according to AMA and house style. The corresponding author will receive a copyedited manuscript for review prior to publication.
All articles published in print are subsequently published open access on the JCP website.